| Latest Forum Topics / New Silkroutes |
|
|
Tranforming to be a Healthcare Stock.. Good or Bad
|
|||||
|
Starship
Supreme |
22-Jan-2021 11:11
|
||||
|
x 0
x 0 Alert Admin |
As expected. What a scam. This scenario has been played out countless times in SGX over the years and deccades. Yet, many gamblers continue to offer themselves as sacrificial lambs to the slaughter.  ![]() ![]() ![]()   |
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
20-Jan-2021 08:33
|
||||
|
x 0
x 0 Alert Admin |
Anything is possible in this market. Just look at a sleeping counter like Nutryfarm. Just a bit of durian business is enough to cause the share price to rocket from below $0.10 to $0.50 New Silkroutes has a pretty small float which makes it equally volatile as Nutrifarm.   |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Deepimpact
Senior |
20-Jan-2021 04:03
|
||||
|
x 0
x 0 Alert Admin |
Sibeh lihai
|
||||
| Useful To Me Not Useful To Me | |||||
|
Laggard
Senior |
19-Jan-2021 22:47
|
||||
|
x 0
x 0 Alert Admin |
Genomic + AI the Buzz words.......  https://www.forbes.com/sites/oliviergarret/2020/05/14/genomic-stocks-are-in-the-first-inning-of-a-multi-year-megatrend/ But, do they have what it take to excel or just hips. |
||||
| Useful To Me Not Useful To Me | |||||
|
shk363
Elite |
19-Jan-2021 14:56
|
||||
|
x 0
x 0 Alert Admin |
try some for rocket to 50 cents | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Starship
Supreme |
19-Jan-2021 13:27
|
||||
|
x 0
x 0 Alert Admin |
Signs of another Biolidics? " The MOU does not involve any commitment of funding, and both parties will sign a binding agreement should they decide to take the collaboration to the next level, the company said."
|
||||
| Useful To Me Not Useful To Me | |||||
|
Starship
Supreme |
19-Jan-2021 13:14
|
||||
|
x 0
x 0 Alert Admin |
What a joke. Up 207% with just 4+m shares traded worth only $1m !!!!!  ![]()
|
||||
| Useful To Me Not Useful To Me | |||||
|
Starship
Supreme |
19-Jan-2021 13:11
|
||||
|
x 0
x 0 Alert Admin |
Oh, there' s a NewSilkroad news released at the same time last night. Coincidence or planned? New Silkroutes explores working with Huawei on genomic medicine MON, JAN 18, 2021 - 9:13 PM NEW Silkroutes Group has inked an agreement with Huawei International to develop an artificial intelligence (AI) platform that can be used in genomics-driven healthcare, the mainboard-listed investment holding company said on Monday. Under a memorandum of understanding, New Silkroutes and Huawei will extensively explore a collaboration to use AI to establish " breakthrough analyses" of genomic data and develop predictive models for diagnoses, therapeutics and prognoses in oncology and genomics, New Silkroutes said in an exchange filing. Huawei International is the overseas arm of Huawei serving customers in Singapore. Its Shenzhen-based parent is a leading global provider of information and communications technology infrastructure and smart devices, New Silkroutes said. VicPearly Wong, chief executive of New Silkroutes, said: " The new strategic growth of New Silkroutes is towards AI-driven solutions and digital transformation in the healthcare sector. We are excited to collaborate with Huawei, a global technology leader, to develop valuable and innovative breakthroughs in genomics-driven healthcare." Genomic medicine involves the study of patients' DNA, which can lead to improved clinical care and personalised treatment. Using big data, AI can speed up the analysis of vast amounts of genomic sequence data so that doctors and patients can identify and manage conditions at the earliest possible stages, the company said. The MOU does not involve any commitment of funding, and both parties will sign a binding agreement should they decide to take the collaboration to the next level, the company said. Dr Wong was appointed executive director in November 2020, after the company announced the previous month that non-independent, non-executive chairman Goh Jin Hian had resigned. Dr Goh, the medically-trained son of former Singapore prime minister Goh Chok Tong, was the company' s CEO until Oct 1. Since taking the helm, Dr Wong has worked with its board of directors to order a strategic review of the group' s International Energy Group and to commence a voluntary creditors' winding up of the subsidiary, the company said. New Silkroutes has also appointed KPMG Services to conduct an independent review into two earlier management agreements entered into by its China subsidiary, Shanghai Fengwei Garment Accessory, as well as into the valuation of a 4.5 per cent stake in Thai General Nice Coal and Coke, it added. " I am pleased to say that we are nearing the end of removing loss-making legacy businesses and restructuring NSG so that we can build a strong momentum to pivot fully into healthcare," Dr Wong said. New Silkroutes shares rose 0.3 Singapore cents, or 4 per cent, to close at 7.8 Singapore cents on Monday. https://www.businesstimes.com.sg/companies-markets/new-silkroutes-explores-working-with-huawei-on-genomic-medicine |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Starship
Supreme |
19-Jan-2021 13:05
|
||||
|
x 0
x 0 Alert Admin |
Is this the same company or a case of mistaken identity?? Silkroad Nickel teams up with Ganfeng Lithium to tap growing electric vehicle industry MON, JAN 18, 2021 - 8:11 PM CATALIST-listed nickel-ore producer Silkroad Nickel has entered into an exclusive term sheet with lithium-compound producer Ganfeng Lithium to tap the growing electric vehicle (EV) industry. In a bourse filing on Monday, the firm said it will stand to benefit from the booming EV trends around the region by building a strong and synergistic partnership with Ganfeng Lithium. Silkroad Nickel added that it will ensure the availability of raw materials through its mine' s laterite ore, which contains both nickel and cobalt, two key metal components used in lithium-ion battery production. Ganfeng Lithium in turn, will be able to access and participate in the South East Asian market with confidence, and expand its growing business in the EV industry together with Silkroad Nickel. Under the exclusive investment partnership, Ganfeng Lithium will invest a three-year convertible bond of a principal amount of US$15 million, which has an interest rate of 7 per cent per annum. Ganfeng Lithium, at its sole option (subject to both parties obtaining legal advice), has the right to convert the entire principal amount of the convertible bond six months after the issue of the convertible bond into new shares, amounting to a 25 per cent equity interest in either Silkroad Nickel' s wholly owned subsidiaries FE Resources (FER) or PT Anugrah (PT ATS) in Singapore and Indonesia respectively. Ganfeng Lithium also has a call option to subscribe for additional new shares in either FER or PT ATS upon conversion of the convertible bond however, the aggregate equity interest in FER or PT ATS that Ganfeng Lithium acquires shall not exceed 50 per cent, subject to a final agreed valuation. In addition, Ganfeng Lithium will enter into 10-year nickel-ore offtake contract with PT ATS for the supply, at market price, of at least a million tonnes per annum with an option to increase the volume by an additional 0.5 million tonnes per annum and extend the offtake contract for a further five years. Silkroad Nickel in its bourse filing: " The group foresees many mutual benefits and synergistic opportunities from this partnership, and views it as a step forward in its vision towards becoming a vertically-integrated key nickel and cobalt supplier and processor to the EV industry." Hong Kah Ing, executive director and chief executive officer of Silkroad Nickel said: " We are pleased to announce and embark on this exclusive partnership with Ganfeng Lithium, a world leader in lithium-ion batteries and electric vehicles. As the demand for EV accelerates across the world, Indonesia has emerged as a key player in the global EV ecosystem and we are excited to be part of this exciting supply chain." https://www.businesstimes.com.sg/companies-markets/silkroad-nickel-teams-up-with-ganfeng-lithium-to-tap-growing-electric-vehicle   |
||||
| Useful To Me Not Useful To Me | |||||
|
teeth53
Supreme |
19-Jan-2021 13:03
Yells: "don't learn through life, learn to grow with life " |
||||
|
x 0
x 0 Alert Admin |
Maybe prime target for take over...hahaha. | ||||
| Useful To Me Not Useful To Me | |||||
|
teeth53
Supreme |
19-Jan-2021 12:41
Yells: "don't learn through life, learn to grow with life " |
||||
|
x 0
x 0 Alert Admin |
Huat.ka.seow...u neber know. $2000, today worth $260,000/-
|
||||
| Useful To Me Not Useful To Me | |||||
|
Lightyear
Veteran |
19-Jan-2021 12:11
|
||||
|
x 0
x 0 Alert Admin |
Interesting for this sudden surge | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
teeth53
Supreme |
19-Jan-2021 11:26
Yells: "don't learn through life, learn to grow with life " |
||||
|
x 0
x 0 Alert Admin |
New Silkroutes. Liow Goh, son coy.☆ 》 suddenly spring up 233.3% in today morning trade with 3,815.8m shr traded.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Laggard
Senior |
20-Dec-2020 23:20
|
||||
|
x 0
x 0 Alert Admin |
What will these reviews will lead to..... Review the agreement is beneficial  Review the placement/ acquisition of Fengwei back in 2018/19 will involve the biggest and  substantial shareholder as well the profitable part of group business. Review on Oil business will shrink thh the group business by a lot, what is left will be little in core business. These doesn' t argue well for the stock, a rough road ahead for the new CEO and Board.   |
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
19-Dec-2020 13:56
|
||||
|
x 0
x 0 Alert Admin |
New Silkroutes appoints KMPG to carry out independent review
 
NEW Silkroutes Group has appointed KPMG Services to carry out an independent review regarding two agreements involving a China unit, and the valuation of its stake in a Thai firm.
 
KPMG will report directly to the Singapore Exchange' s regulatory arm (SGX RegCo) and New Silkroutes' audit and risk committee.
 
This comes after independent external auditor Deloitte & Touche included a disclaimer of opinion on the group' s financial statements for the fiscal year ended June 30.
 
Deloitte said in its Oct 14 report that it was unable to obtain sufficient audit evidence on matters including the business rationale, commercial substance and structuring of two agreements that New Silkroutes' wholly-owned subsidiary Shanghai Fengwei Garment Accessory (SFGA) signed with a Chinese entity in April.
 
New Silkroutes disclosed that the Chinese entity is Shanghai Minlin New Textile Materials Sales Centre. Its ultimate beneficial owner, Lin Jie, is an acquaintance of New Silkroutes' executive director and substantial shareholder, Shen Yuyun.
 
In addition, Deloitte had said it could not determine the appropriateness of the valuation methodology used for Thai General Nice Coal and Coke.
 
New Silkroutes holds 4.5 per cent of the Thai entity and had classified this stake as a financial asset at fair value through other comprehensive income. It recorded a fair-value loss of US$2.5 million in FY20, bringing its value to US$17.2 million. But the Thai firm had not begun operating by end-June.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
16-Dec-2020 09:26
|
||||
|
x 0
x 0 Alert Admin |
New Silkroutes undertakes strategic review of physical oil trading division
 
NEW Silkroutes Group has started a strategic review of its physical oil trading division, IEG, which has been hit by a " significant reduction" in trading volumes and lower oil prices.
 
The review will include exploring options to scale down, divest, enter into arrangements with creditors, or wind up the oil and trading business of IEG, the mainboard-listed group said on Tuesday.
 
This comes as New Silkroutes incurred a net loss after tax of approximately US$8.2 million for the financial year ended June 30, largely due to the oil and gas segment. The group added that it is expecting more provisions of expected credit loss while trying to recover the remaining trade and other receivables amid the pandemic.
 
In addition, IEG' s subsidiary, TXZ Tankers Pte Ltd, has been experiencing " challenging situations" in view of the decrease in shipping charters.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
18-Nov-2020 09:44
|
||||
|
x 0
x 0 Alert Admin |
New Silkroutes appoints CEO as executive director, new finance director
 
HEALTHCARE and energy firm New Silkroutes Group has appointed chief executive officer (CEO) VicPearly Wong as its executive director, and Lincoln Kwok as its finance director.
 
With the additional role, Dr Wong, 44, is responsible for the overall management and operations of the group, as well as facilitating and managing the company, New Silkroutes said in a bourse filing on Monday evening.
 
Meanwhile, Mr Kwok, 44, is responsible for the group' s treasury, finance, audit and strategic planning functions. These include fundraising, developing and maintaining banking relationships, and assisting the CEO in assessing and structuring corporate finance deals and investments, New Silkroutes said.
 
Prior to this, Mr Kwok was financial controller at Hong Kong-listed Pipeline Engineering Holdings, which offers infrastructure pipeline construction and related engineering services.
 
Dr Wong and Mr Kwok' s appointments come after the mainboard-listed firm in October announced that non-independent, non-executive chairman Goh Jin Hian and finance director William Teo Thiam Chuan have resigned.
 
New Silkroutes said then that Dr Goh stepped down as its chairman to " focus on personal matters and to pursue other interests" .
 
Mr Teo, meanwhile, stepped down " to devote more time to his personal affairs" , it added.
 
The resignations of the two New Silkroutes directors also came after the firm announced on Oct 15 that its auditor Deloitte & Touche has given a disclaimer of opinion on the financial statements of the group for the financial year ended June 30.
 
At the same time, Dr Goh also quit as independent director of cord-blood banking firm Cordlife Group.
 
Dr Goh, the medically-trained son of former Singapore prime minister Goh Chok Tong, was New Silkroutes' CEO till Oct 1, when he assumed the position of non-executive chairman.
 
He also quit as Cordlife' s chairman in early October, after Inter-Pacific Petroleum' s (IPP) judicial managers sued him in relation to an alleged breach of director' s duties.
 
New Silkroutes previously noted that Dr Goh and Mr Teo were assisting the Commercial Affairs Department with investigations. The company said it understands that the alleged offence is false trading and market rigging in view of past share buybacks and acquisitions of shares.
 
Also assisting with the investigation is Kelvyn Oo, who was the executive director and chief corporate officer of New Silkroutes until he left on Aug 1.
 
Separately, New Silkroutes had also said that Dr Goh was suitable to continue as a board member despite the IPP litigation, because that is a civil suit against him and the allegations are without merit, based on his lawyers' legal advice.
 
Most recently in late October, New Silkroutes said it will appoint an independent public accounting firm to review matters relating to two of its agreements involving a China unit, and the valuation of its stake in a Thai firm.
 
This comes after Deloitte said in its Oct 14 report that it was unable to obtain sufficient audit evidence on matters including the business rationale, commercial substance and structuring of two agreements that New Silkroutes' wholly-owned subsidiary Shanghai Fengwei Garment Accessory signed with a Chinese entity in April.
 
Deloitte had also said it could not determine the appropriateness of the valuation methodology used for Thai General Nice Coal and Coke.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
30-Oct-2020 10:51
|
||||
|
x 0
x 0 Alert Admin |
New Silkroutes plans independent review of deals signed with China entity
HEALTHCARE and energy firm New Silkroutes Group will appoint an independent public accounting firm to review matters relating to two of its agreements involving a China unit, and the valuation of its stake in a Thai firm.
 
This comes after independent external auditor Deloitte & Touche included a disclaimer of opinion on the group' s financial statements for the fiscal year ended June 30.
 
Deloitte said in its Oct 14 report that it was unable to obtain sufficient audit evidence on matters including the business rationale, commercial substance and structuring of two agreements that New Silkroutes' wholly-owned subsidiary Shanghai Fengwei Garment Accessory (SFGA) signed with a Chinese entity in April.
 
New Silkroutes disclosed that the Chinese entity is Shanghai Minlin New Textile Materials Sales Centre. Its ultimate beneficial owner, Lin Jie, is an acquaintance of New Silkroutes' executive director and substantial shareholder, Shen Yuyun.
 
New Silkroutes and SFGA signed a management agreement (MA) with Shanghai Minlin, which gives New Silkroutes a guaranteed profit of US$2.8 million from SFGA' s operations for the year to Dec 31, 2021. Shanghai Minlin will take any excess profits or bear any excess losses.
 
SFGA and Shanghai Minlin also signed a management-service agreement (MSA), under which SFGA is to receive services such as human resource management, corporate image planning, production process management, marketing development and financial management from Shanghai Minlin.
 
In response to the Singapore Exchange' s (SGX) queries, New Silkroutes said on Wednesday night that the need to ease its cash flow was a key reason for inking the MA.
 
The independent review will cover the commercial substance of the MA and MSA. It will also look into potential tax exposures and the impact of any non-compliance with regulatory or legal requirements from the MSA.
 
New Silkroutes noted that SFGA' s revenue had increased by about 100 million yuan (S$20.6 million) after both the MA and MSA were inked, thanks to new orders introduced by Shanghai Minlin.
 
Deloitte also said it could not determine the appropriateness of the valuation methodology used for Thai General Nice Coal and Coke.
 
New Silkroutes holds 4.5 per cent of the Thai entity and had classified this stake as a financial asset at fair value through other comprehensive income. It recorded a fair-value loss of US$2.5 million in FY20, bringing its value to US$17.2 million.
 
But the Thai firm had not begun operating by end-June.
 
New Silkroutes said it believes the valuation is reasonable and appropriate, but that the board and the management would explore with the incoming auditors on other methods of valuation that are acceptable.
 
Deloitte' s disclaimer of opinion was published on the same day the company announced that chairman Goh Jin Hian and finance director William Teo had quit.
 
Separately, Dr Goh and Mr Teo have been assisting the Commercial Affairs Department with its investigation into alleged false trading and market rigging.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
21-Oct-2020 09:07
|
||||
|
x 0
x 0 Alert Admin |
New Silkroutes appoints Darrell Lim as acting independent non-executive chairman
TROUBLED healthcare provider New Silkroutes Group announced the appointment of Darrell Lim Chee Lek as acting independent non-executive chairman of the board with effect from Oct 20.
 
He replaces former chairman Goh Jin Hian, the son of former Singapore prime minister Goh Chok Tong, who resigned amid investigations by the Commercial Affairs Department (CAD) earlier this month.
 
Mr Lim was appointed to the board of New Silkroutes on Aug 1, 2020 as an independent, non-executive director, and became lead independent director this month. As at late July he was listed as the executive board director of BRC Asia, co-founder of hedge fund Bright Point Capital and non-executive director of XM Studios. He was formerly the head of investor relations at the Singapore Exchange.
 
Other members of the board include Shen Yuyun, who is executive director, Vivien Chen Chou Mei Mei as independent non-executive director, Andrew Chua Soon Kian as non-independent non-executive director and Alex Chua Siong Kiat as independent non-executive director.
 
On Sept 30, the company disclosed that Dr Goh and then-finance director William Teo Thiam Chuan were being investigated by the CAD over a possible offence under the Securities and Futures Act.
 
New Silkroutes said then that it understood that the alleged offence was false trading and market rigging to do with past share buy-backs and share acquisitions.
 
Mr Teo has also since quit the company. Another director who has recently left New Silkroutes is Kelvyn Oo, where he had been executive director and chief corporate officer until he stepped down on Aug 1. He is also assisting with the CAD probe.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Jamesbond007
Veteran |
19-Oct-2020 15:11
|
||||
|
x 0
x 0 Alert Admin |
One main issue in the whole episode, Integrity comes in short supply. | ||||
| Useful To Me Not Useful To Me | |||||




